Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clovis Oncology Inc (NQ: CLVS )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clovis Oncology Inc

< Previous 1 2 3 4 5 6 7 Next >
Mid-Afternoon Market Update: Dow Drops Over 50 Points; Comtech Telecommunications Shares Plunge
Toward the end of trading Wednesday, the Dow traded down 0.16% to 34,545.82 while the NASDAQ rose 0.26% to 13,960.49. The S&P also rose, gaining 0.07% to 4,230.24. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Aethlon Medical (NASDAQ:AEMD) shares moved upwards by 347.96% to $9.9 during Wednesday's regular session. As of 12:30 EST, Aethlon Medical's stock is... 
Via Benzinga
CLVS Stock: Is a Reddit-Fueled Short Squeeze Brewing for Clovis Oncology?
Clovis is joining the myriad of other big Reddit-stock winners this morning as retail traders move huge amounts of CLVS stock. 
Via InvestorPlace
Why Clovis Oncology Stock Is Rocketing Higher Today
This unloved biotech is finding new life on social media. 
Via The Motley Fool
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Exposures Product Safety
48 Stocks Moving In Wednesday's Mid-Day Session
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares jumped 371% to $10.41 in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 248.41% to $7.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $93.4... 
Via Benzinga
28 Stocks Moving in Wednesday's Pre-Market Session
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) rose 72.4% to $3.81 in pre-market trading following Zacks article 'AEMD: First Ever In Vivo Removal Of COVID Virus From... 
Via Benzinga
Could Clovis Oncology Stock Be Gearing Up For Its Next Move?
Clovis Oncology Inc. (NASDAQ: CLVS) is gearing up to present this week at the American Society of Clinical Oncology annual meeting, which runs June 4-8. The company is... 
Via Benzinga
10 Current And Former Penny Stocks With High Short Interest As BB & GME Stock Attract More Reddit Interest
Reddit stocks have surged thanks to big moves in BB and GME. With short interest as the focus, here are a few penny stocks to watch right now. 
Via Talk Markets
Clovis Oncology Highlights Rubraca® (rucaparib) and Lucitanib Data at 2021 ASCO Annual Meeting
From Clovis Oncology, Inc.
Via Business Wire
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Onconova Therapeutics (NASDAQ:ONTX) shares moved upwards by 41.84% to $0.88 during Tuesday's regular session. As of 12:30 EST, this security is trading at a... 
Via Benzinga
Why Clovis Oncology Stock Is Trading Lower Today
Clovis Oncology (NASDAQ: CLVS) shares are trading lower after the company announced a $75 million at-the-market equity offering program. Clovis Oncology intends to use the net... 
Via Benzinga
The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Venus Concept (NASDAQ:VERO) share... 
Via Benzinga
Clovis Oncology Announces At-The-Market Equity Offering Program
From Clovis Oncology, Inc.
Via Business Wire
70 Biggest Movers From Yesterday
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters... 
Via Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares jumped 64.9% to $7.75 after the company reported an order for 200,000 sugarBEAT sensors. Chiasma, Inc. (NASDAQ: CHMA) gained 53... 
Via Benzinga
What Is Going On With Clovis Oncology Today?
Clovis Oncology Inc (NASDAQ: CLVS) is trading higher on Wednesday after the company reported better-than-expected first-quarter earnings. What Happened: Clovis Oncology reported... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Chiasma (NASDAQ:CHMA) stock moved upwards by 39.04% to $3.95 during Wednesday's pre-market session. The market value of their outstanding shares is at $228.4... 
Via Benzinga
Clovis Oncology Announces First Quarter 2021 Operating Results
From Clovis Oncology, Inc.
Via Business Wire
Clovis Oncology to Present at the Bank of America 2021 Health Care Conference
From Clovis Oncology, Inc.
Via Business Wire
Clovis Oncology to Announce First Quarter 2021 Financial Results and Host Webcast Conference Call on May 5
From Clovis Oncology, Inc.
Via Business Wire
Clovis Oncology Highlights Rubraca® (rucaparib) Clinical Data at AACR Virtual Annual Meeting 2021
From Clovis Oncology, Inc.
Via Business Wire
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.